SIGNALS◐ DEVELOPINGI · Intelligence◆ Concentrating
Novartis buys Myricx Bio to deepen ADC payload pipeline
Jul 6, 2026SOURCE: globenewswire.com
SO WHAT
Meaningful choice in oncology is still being privatized upstream, where platform control matters more than the drug itself.
The acquisition adds Myricx’s NMTi payload work to Novartis’s next-generation antibody-drug conjugate push. In the wire, that is less a purchase than a claim on the next layer of cancer-engineering capacity.
This is Negative Resistance’s reframed reading of a reported signal. The headline and analysis above are our interpretation through the thousand-day-window lens. The original reporting lives at the source linked above.